Bioline Rx reported $-977K in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Arca Biopharma USD -21M 4.78M Mar/2025
Bio Path USD -2.85M 99K Mar/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -24.39M 17.27M Mar/2025